|
Volumn 72, Issue 24, 2012, Pages 6319-6324
|
A blueprint for an international cancer epigenome consortium. A report from the AACR cancer epigenome task force
a b d e h f j i g c k g |
Author keywords
[No Author keywords available]
|
Indexed keywords
5 AZA 2' DEOXYCYTIDINE;
AZACITIDINE;
ENTINOSTAT;
ROMIDEPSIN;
VORINOSTAT;
CANCER GENETICS;
CANCER GROWTH;
CARCINOGENESIS;
CELL ISOLATION;
CELL TYPE;
COMPUTER ANALYSIS;
COMPUTER INTERFACE;
CUTANEOUS T CELL LYMPHOMA;
CYTOGENETICS;
DNA METHYLATION;
EPIGENETICS;
GENE MAPPING;
GENE MUTATION;
GENE TARGETING;
GENE TECHNOLOGY;
GENETIC DATABASE;
GENETIC HETEROGENEITY;
GENETIC LINKAGE;
GENOMICS;
HISTONE MODIFICATION;
HUMAN;
HUMAN GENOME;
INTERNATIONAL CANCER EPIGENOME PROJECT;
LUNG NON SMALL CELL CANCER;
MYELODYSPLASTIC SYNDROME;
PRIORITY JOURNAL;
SHORT SURVEY;
SOMATIC MUTATION;
TUMOR CELL;
WEB BROWSER;
ADVISORY COMMITTEES;
BIOMEDICAL RESEARCH;
COMPUTATIONAL BIOLOGY;
CONSENSUS;
DRUG DISCOVERY;
EPIGENESIS, GENETIC;
EPIGENOMICS;
HUMANS;
INTERNATIONALITY;
MOLECULAR TARGETED THERAPY;
NEOPLASMS;
PRACTICE GUIDELINES AS TOPIC;
RESEARCH REPORT;
SOCIETIES, SCIENTIFIC;
UNITED STATES;
|
EID: 84871232475
PISSN: 00085472
EISSN: 15387445
Source Type: Journal
DOI: 10.1158/0008-5472.CAN-12-3658 Document Type: Short Survey |
Times cited : (22)
|
References (3)
|